NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $3.22 -0.02 (-0.62%) Closing price 04:00 PM EasternExtended Trading$3.20 -0.02 (-0.56%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cronos Group Stock (NASDAQ:CRON) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cronos Group alerts:Sign Up Key Stats Today's Range$3.15▼$3.2450-Day Range$2.72▼$3.5552-Week Range$2.28▼$3.61Volume974,238 shsAverage Volume882,443 shsMarket Capitalization$1.19 billionP/E Ratio16.10Dividend YieldN/APrice Target$2.30Consensus RatingModerate Buy Company Overview Cronos Group Inc. is a Toronto-based cannabis company that develops, produces and distributes cannabis and cannabis-derived products. The company focuses on branded consumer products, including dried cannabis flower, pre-rolls, vaporizers, edibles and extracts. Cronos markets products under brands such as Spinach, PEACE NATURALS and Lord Jones. Brand availability varies by market and product category, with the company serving regulated cannabis markets in Canada and pursuing international opportunities where permitted by local laws. Founded in 2013, Cronos has expanded through brand development, acquisitions and strategic investments. The company is led by Mike Gorenstein, who serves as chairman and chief executive officer.AI Generated. May Contain Errors. Read More Cronos Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks26th Percentile Overall ScoreCRON MarketRank™: Cronos Group scored higher than 26% of companies evaluated by MarketBeat, and ranked 761st out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.7 / 5Analyst RatingModerate Buy Consensus RatingCronos Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and no sell ratings.Downside RiskCronos Group has a consensus price target of $2.30, representing about 28.6% downside from its current price of $3.22.Amount of Analyst CoverageCronos Group has only been the subject of 2 research reports in the past 90 days.Read more about Cronos Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is 16.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.83.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is 16.10, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.15.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.96% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 4.11.Change versus previous monthShort interest in Cronos Group has recently increased by 0.26%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.45 News SentimentCronos Group has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Cronos Group this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows8 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by Insiders7.80% of the stock of Cronos Group is held by insiders.Percentage Held by Institutions8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRON Stock News HeadlinesCronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026October 8 at 8:45 AM | finance.yahoo.comCronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026October 8 at 7:30 AM | globenewswire.comA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, and predictions. He argues a simpler approach can work just as well. His free report, The Simple Path To Success With Options, breaks down a repeatable trade setup, common rookie mistakes, and step-by-step blueprints designed to cut through market noise. No complex charts. No guesswork. Just a straightforward setup anyone can learn.October 8 at 1:00 AM | TradeWins (Ad)Contrasting Eton Pharmaceuticals (NASDAQ:ETON) & Cronos Group (NASDAQ:CRON)October 8 at 4:15 AM | americanbankingnews.comCronos Group Inc. (NASDAQ:CRON) Stock Now Rated "Moderate Buy" by Wall Street AnalystsOctober 7 at 6:29 AM | americanbankingnews.comIs Cronos Group (TSX:CRON) A Bargain Following Its Proposed $10 Million Settlement?October 5 at 1:20 PM | finance.yahoo.comHeavy metal legend Cronos dies at 63, leaving Venom’s extreme metal legacyOctober 3, 2026 | msn.comCritical Analysis: Theravance Biopharma (NASDAQ:TBPH) & Cronos Group (NASDAQ:CRON)September 30, 2026 | americanbankingnews.comSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.63 on January 1st, 2026. Since then, CRON stock has increased by 22.4% and is now trading at $3.22. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) issued its quarterly earnings results on Thursday, August, 6th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.08. The company had revenue of $53.01 million for the quarter, compared to analysts' expectations of $44.20 million. Cronos Group had a trailing twelve-month return on equity of 4.85% and a net margin of 39.08%. Read the conference call transcript. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/06/2026Today10/08/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CRON's financial health is in the Green zone, according to TradeSmith. CRON has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CRON CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees610Year Founded2013Price Target and Rating Average Price Target for Cronos Group$2.30 High Price Target$2.30 Low Price Target$2.30 Potential Upside/Downside-28.6%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$0.20 Trailing P/E Ratio16.10 Forward P/E Ratio29.27 P/E GrowthN/ANet Income-$9.45 million Net Margins39.08% Pretax Margin38.23% Return on Equity4.85% Return on Assets4.62% Debt Debt-to-Equity RatioN/A Current Ratio16.18 Quick Ratio15.25 Sales & Book Value Annual Sales$146.59 million Price / Sales8.10 Cash Flow$0.01 per share Price / Cash Flow258.44 Book Value$3.00 per share Price / Book1.07Miscellaneous Outstanding Shares368,540,000Free Float339,797,000Market Cap$1.19 billion OptionableOptionable Beta0.90 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:CRON) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredWall Street Legend: “Global Market Freeze Coming”Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehm...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredThe national debt just passed $39 trillionThe U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...US Gold Bureau | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
